HIV Infections: all 4,342 studies
Page 16 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS PatientsCompletedNCT04084444Phase 2
- Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention DevelopmentCompletedNCT04077138
- A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV InfectionCompletedNCT04076423Phase 4
- Determining Bacterial Communities in the Lungs of HIV-infected Individuals With COPD in Uganda.Status unknownNCT04070248
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEPCompletedNCT04066881Phase 2
- Camu Camu in ART-treated People Living with HIVCompletedNCT04058392Phase 1
- Development and Implementation of an HIV-testing Intervention for Primary Care in BelgiumCompletedNCT04056156Not applicable
- Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF)CompletedNCT04054089Phase 4
- Theory-based HIV Disclosure Intervention for ParentsCompletedNCT04051177Not applicable
- Zepatier in Patients with Substance UseCompletedNCT04048850
- Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in ZimbabweCompletedNCT04048629Not applicable
- Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young WomenStatus unknownNCT04044235Not applicable
- Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult ParticipantsWithdrawnNCT04041674Phase 1
- Positive Affect Promotion to Empower Optimal Adherence to HIV TherapyCompletedNCT04035759Phase 1
- Impact of DOlutegravir+Lamivudine Simplification on HIV-1 ReservoirsCompletedNCT04034862Phase 3
- Same-Day Antiretroviral Therapy InitiationActive, not recruitingNCT04032028
- The Deliver Health StudyCompletedNCT04027153Not applicable
- Testing an Online Intervention to Improve Parents' Communication With Gay and Bisexual Sons About Sex and HIVCompletedNCT04018573Not applicable
- Task Shifting to Treat Depression and HIV Medication Nonadherence in Low Resource SettingsCompletedNCT04018391Not applicable
- Tenofovir Rectal Douche to Prevent HIV TransmissionCompletedNCT04016233Phase 1
- Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in KenyaCompletedNCT04013295Not applicable
- Medication Adherence and Outcomes Among Patients in United States With HIVCompletedNCT03995745Not applicable
- 2000 HIV Human Functional Genomics Partnership ProgramCompletedNCT03994835
- Implementation and Evaluation of an Electronic Alert to Encourage Targeted Screening for HIV Infection at Foch Hospital According to Socio-demographic CriteriaCompletedNCT03991767Not applicable
- Nucleosides And Darunavir/Dolutegravir In AfricaStatus unknownNCT03988452Phase 3
- The CHAPS Trial: Combined HIV Adolescent PrEP and PreventionCompletedNCT03986970Phase 2
- Role of the Balano-preputial Furrow 's Microbiota, in Circumcised Patients or Not, in the Acquisition or Transmission of HIVStatus unknownNCT03985137
- Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old ChildrenStatus unknownNCT03984552
- HIV Results Exchange Mechanism on Promoting HIV Testing Among MSMStatus unknownNCT03984136Not applicable
- Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent ReservoirCompletedNCT03980691Phase 1
- Utilizing the HITSystem for Optimizing Paediatric ART Retention and Adherence in Western Nyanza Province, KenyaStatus unknownNCT03980119Not applicable
- Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) ScreeningCompletedNCT03979144
- Peer-Educator-coordinated vs Nurse-coordinated ART Refill for Adolescents and Young Adults Living With HIV in LesothoCompletedNCT03969030Not applicable
- Syndemics and Loss from the HIV Care Continuum in India - InterventionCompletedNCT03966586Not applicable
- Primary Resistance in HIV Patients in ColombiaCompletedNCT03957369
- Assessing the Effectiveness and Feasibility of Voluntary Assisted Partner Notification ServicesStatus unknownNCT03944395Not applicable
- Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure ProphylaxisCompletedNCT03930654Not applicable
- Trans People Living With HIV Throughout EuropeCompletedNCT03922269
- Analysis of the Nasal Mucosal Immune Response in HIV InfectionStatus unknownNCT03920709
- Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDSWithdrawnNCT03916783Not applicable
- Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep SouthWithdrawnNCT03897725Not applicable
- Getting to Zero: Safer Conception Programming Among HIV Sero-different Couples in UgandaCompletedNCT03895619Not applicable
- Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected VolunteersTerminatedNCT03892161Phase 1
- Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of MenCompletedNCT03891407Phase 1/2
- Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mLStatus unknownNCT03883334Phase 4
- Direct and Spillover Impacts of a Community-Level HIV/AIDS ProgramCompletedNCT03880175Not applicable
- Universal Coverage of Antiretroviral Treatment in SenegalCompletedNCT03880006Not applicable
- Resistance Training in People Living With HIV/AIDSCompletedNCT03879993Not applicable
- Antiretroviral Therapy for Acute HIV InfectionWithdrawnNCT03877536Not applicable
- The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in KenyaCompletedNCT03868644Not applicable
- Evaluation of a Smart Phone App-based Case Management Model Among ART-naive HIV-infected MSMStatus unknownNCT03860116Not applicable
- Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected PatientsCompletedNCT03855176Phase 4
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- Study on the Response to Tetanus Vaccination of People Living With HIVCompletedNCT03853681Not applicable
- Rapid Build of HIV Related Protective BarriersStatus unknownNCT03852849Not applicable
- Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP StudyStatus unknownNCT03842488Phase 4
- Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenWithdrawnNCT03834571Phase 2
- Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole TherapyStatus unknownNCT03827278Not applicable
- Growth Hormone Dynamics and Cardiac Steatosis in HIVCompletedNCT03826160
- Optimizing mHealth for Adherence Monitoring and InterventionCompletedNCT03825952Not applicable
- Impact of Point-of-Care EID for HIV-Exposed InfantsCompletedNCT03824067Not applicable
- Helping Men Have Healthy BabiesCompletedNCT03818984Not applicable
- Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South AfricaCompletedNCT03809364Not applicable
- Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional IncentivesCompletedNCT03808194Not applicable
- Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected AdolescentsCompletedNCT03800394
- Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) TabletCompletedNCT03800381
- Optimisation of Care in Vulnerable HIV Infected IndividualsCompletedNCT03799276Not applicable
- The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV MedicationCompletedNCT03794648Not applicable
- Bringing South African Men Into HIV Counseling and Testing and CareCompletedNCT03794245Not applicable
- Impact of Physical Activity and Diet on Symptom Experience in People Living With HIVStatus unknownNCT03790501
- The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced PatientsCompletedNCT03789968
- Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected WomenStatus unknownNCT03789513Not applicable
- Early Access to ART for All in Swaziland: Effects on Economic OutcomesCompletedNCT03789448Not applicable
- Improving Prevention Systems to Reduce Disparities for High Priority PopulationsCompletedNCT03778164Not applicable
- Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This SituationCompletedNCT03777371
- What Happens in Vegas: PEP to PrEP OpportunitiesStatus unknownNCT03775083
- Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With CancerCompletedNCT03767465
- A Mobile Gaming App to Improve ART Adherence for YouthCompletedNCT03760211Not applicable
- Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional CureCompletedNCT03758625Phase 1
- Performance and Usability Evaluation of the Atomo HIV Self-TestCompletedNCT03755986Not applicable
- RA Effect on Cell Surface Molecules in VivoWithdrawnNCT03753867Phase 1
- Gonadal Function in Young to Middle Aged HIV-infected MenCompletedNCT03747003
- Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive PatientsTerminatedNCT03742375Not applicable
- Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD StudyStatus unknownNCT03732625Phase 4
- Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy VolunteersStatus unknownNCT03730311Phase 1
- Impact of HIV-1 and Aging on Mucosal Vaccine ResponsesActive, not recruitingNCT03729778Early Phase 1
- VioOne HIV Profile Supplemental AssayCompletedNCT03727932Not applicable
- Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected IndividualsCompletedNCT03723525Phase 4
- A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected AdultsCompletedNCT03721510Phase 1/2
- Community Based Interventions to Improve HIV Outcomes in Youth: a Cluster Randomised Trial in ZimbabweCompletedNCT03719521Not applicable
- Empiric Treatment for Acute HIV in the EDStatus unknownNCT03711253Phase 4
- Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected PatientsWithdrawnNCT03708861Phase 3
- Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index ClientsStatus unknownNCT03705611Not applicable
- A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected AdultsCompletedNCT03699241Phase 1
- A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)CompletedNCT03685500Phase 4
- Body Composition Sub-study of the D2EFT TrialCompletedNCT03675815Phase 4
- PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in MexicoCompletedNCT03674983Not applicable
- CCR5-modified CD4+ T Cells for HIV InfectionCompletedNCT03666871Phase 1/2
- Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)CompletedNCT03666247Not applicable
- Youth Engagement Study: Intervention to Increase HIV Treatment Engagement and Adherence for Young People Living With HIVCompletedNCT03665532Not applicable